Article
Preoperative BChE serves as prognostic marker in patients with resectable AEG after neoadjuvant chemotherapy
2023-03-09
Abstract excerpt
<h4>Background: </h4> Diminished systemic serum butyrylcholinesterase (BChE), a biomarker for chronic inflammation, cachexia, and advanced tumor stage, has shown to play a prognostic role in various malignancies. Aim of this study was to investigate the prognostic value of pretherapeutic BChE levels in patients with resectable adenocarcinoma of the gastroesophageal junction (AEG), treated with or without neoadjuva...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 759e4255-6796-51c3-a9c8-7c3737bb223c
- DOI
- 10.21203/rs.3.rs-2651948/v1
